Concepedia

Janet E. Davis

JE

15

Publications

802

Citations

13

H-Index

1972

Active since

Affiliations

Drug Discovery Laboratory (Norway)(Current)

Johnson & Johnson (United States)

Duke University

The Ohio State University

Janet E. Davis is an author at Drug Discovery Laboratory (Norway) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1972–2007

15

Publications

15

RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase

Scott Wadsworth, Druie Cavender, Scott A. Beers et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 158 citations

Monoclonal Antibody to HLA-A3

Ann E. Berger, Janet E. Davis, Peter Cresswell · Hybridoma · 1982 · 114 citations

, , +15

6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (RWJ 68354):  A Potent and Selective p38 Kinase Inhibitor

James R. Henry, Kenneth C. Rupert, John H. Dodd et al. · Journal of Medicinal Chemistry · 1998 · 77 citations · Full text

, , +20

Interference with Tissue Factor Prolongs Intrahepatic Islet Allograft Survival in a Nonhuman Primate Marginal Mass Model

Dora M. Berman, Over Cabrera, Norman M. Kenyon et al. · Transplantation · 2007 · 75 citations

T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes.

Peter Schäfer, Liang Wang, Scott Wadsworth et al. · PubMed · 1999 · 69 citations

, , +21

Rows per page

1–5 of 15